Laparoscopic versus open cytoreductive nephrectomy in advanced renal-cell carcinoma

Journal of Endourology

Volumn 20, Issue 7, 2006, Pages 504-508

  Eisenberg, Manuel S ^a   Meng, Maxwell V ^a,b,c   Master, Viraj A ^a   Stoller, Marshall L ^a   Rini, Brian I ^c   Carroll, Peter R ^a,c   Kane, Christopher J ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CANCER IMMUNOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HOSPITALIZATION; HUMAN; INFERIOR CAVA VEIN; KIDNEY CARCINOMA; LAPAROSCOPIC SURGERY; MALE; METASTASIS; NEPHRECTOMY; OPERATION DURATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURGICAL APPROACH; SURGICAL TECHNIQUE; TUMOR THROMBUS; TUMOR VOLUME;

CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; LAPAROSCOPY; MALE; MIDDLE AGED; NEPHRECTOMY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33746110611     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2006.20.504     Document Type: Article

References (14)

1. Bhayani SB, Clayman RV, Sundaram CP, et al. Surgical treatment of renal neoplasia: Evolving toward a laparoscopic standard of care. Urology 2003;62:821.
2. Makhoul B, Taille A de la, Vordos D, et al. Laparoscopic radical nephrectomy for T1 renal cancer: The gold standard? A comparison of laparoscopic vs open nephrectomy. BJU Int 2004;93:67.
3. Shuford MD, McDougall EM, Chang SS, et al. Complications of contemporary radical nephrectomy: Comparison of open vs. laparoscopic approach. Urol Oncol 2004;22:121.
4. Desai MM, Gill IS, Ramani AP, et al. Laparoscopic radical nephrectomy for cancer with level I renal vein involvement. J Urol 2003;169:487.
5. Walther MM, Lyne JC, Libutti SK, et al. Laparoscopic cytoreductive nephrectomy as preparation for administration of systemic interleukin-2 in the treatment of metastatic renal cell carcinoma: A pilot study. Urology 1999;53:496.
6. Flanigan RC, Mickisch G, Sylvester R, et al. Cytoreductive nephrectomy in patients with metastatic renal cancer: A combined analysis. J Urol 2004;171:1071.
7. Mickisch G, Garin A, van Poppel H, et al. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: A randomised trial. Lancet 2001;358:966.
8. Meng MV, Miller TR, Cha I, et al. Cytology of morcellated renal specimens: Significance in diagnosis and dissemination. J Urol 2003;169:45.
9. Fornara P, Doehn C, Friedrich HJ, et al. Nonrandomized comparison of open flank versus laparoscopic nephrectomy in 249 patients with benign renal disease. Eur Urol 2001;40:24.
10. Novitsky YW, Litwin DEM, Callery MP. The net immunologic advantage of laparoscopic surgery. Surg Endosc 2004;18:1411.
11. Finelli A, Kaouk JH, Fergany AF, et al. Laparoscopic cytoreductive nephrectomy for metastatic renal cell carcinoma. BJU Int 2004;94:291.
12. Rabets JC, Kaouk JH, Fergany AF, et al. Laparoscopic versus open cytoreductive nephrectomy for metastatic renal cell carcinoma. Urology 2004;64:930.
13. Dunn MD, Portis AJ, Shalhav AL, et al. Laparoscopic versus open radical nephrectomy: A 9-year experience. J Urol 2000;164:1153.
14. Meng MV, Kang SM, Duh QY, et al. Laparoscopic live donor nephrectomy at the University of California San Francisco. Clin Transplant 2001:113.